PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.02%
Some net income increase while ORCL is negative at -27.76%. John Neff would see a short-term edge over the struggling competitor.
-24.51%
Both reduce yoy D&A, with ORCL at -2.91%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
92.25%
Well above ORCL's 138.19% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
7.93%
SBC growth well above ORCL's 10.88%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-47.87%
Negative yoy working capital usage while ORCL is 1113.97%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
194.53%
AR growth well above ORCL's 177.43%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-221.91%
Both reduce yoy inventory, with ORCL at -170.55%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-89.59%
Both negative yoy AP, with ORCL at -154.55%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-172.94%
Negative yoy usage while ORCL is 427.19%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-62.03%
Negative yoy while ORCL is 8.33%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
3.55%
Operating cash flow growth below 50% of ORCL's 64.72%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-3.44%
Both yoy lines negative, with ORCL at -0.69%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
70.85%
Less M&A spending yoy vs. ORCL's 3453.85%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
22.77%
Some yoy expansion while ORCL is negative at -100.26%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-24.36%
Both yoy lines are negative, with ORCL at -4.14%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-67.85%
We reduce yoy other investing while ORCL is 88.56%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-20.37%
Both yoy lines negative, with ORCL at -126.86%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
60.29%
Stock issuance far above ORCL's 59.27%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-16.44%
Both yoy lines negative, with ORCL at -1.44%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.